Free Trial
→ Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (From Paradigm Press) (Ad) Free NRSN Stock Alerts

NeuroSense Therapeutics (NRSN) SEC Filings & 10K Form

NeuroSense Therapeutics logo
$1.27
+0.02 (+1.60%)
(As of 11/1/2024 ET)
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
10/31/2024
3:59 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
7:05 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/27/2024
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/24/2024
8:20 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:25 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:22 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
6:14 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
05/20/2024
3:16 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form F-1/A
05/20/2024
8:02 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
8:02 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
9:21 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:01 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B5
04/10/2024
8:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:32 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/08/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)

Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…

All you have to do is claim your free ticket to the event now…
04/05/2024
8:28 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
4:10 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/04/2024
3:31 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/04/2024
3:37 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
02/22/2024
7:25 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2024
12:20 PM		Gordon Ariel (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
Form SC 13G/A
02/13/2024
9:14 AM		Ben-Noon Alon (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
Form SC 13G/A
02/07/2024
8:38 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:48 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:49 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
4:01 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
4:03 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/21/2023
7:45 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/14/2023
8:41 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2023
2:00 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/05/2023
2:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/05/2023
7:01 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2023
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
12/04/2023
5:17 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
11/28/2023
8:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
9:36 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
11/13/2023
8:28 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
7:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners
Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...
Paradigm Press | Sponsored
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...
Crypto Swap Profits | Sponsored
Sell NVDA Now?
Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...
Chaikin Analytics | Sponsored
Market "Famine" Coming
Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...
Opportunistic Trader | Sponsored
The centerpiece of Trump’s crypto’s masterplan …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...
Weiss Ratings | Sponsored
How Will You Survive A Post Election Retirement Heist?
The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...
American Hartford Gold Group | Sponsored
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored